Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

This study has been terminated.
(This Phase I study was permanently closed to patient accrual on February 23, 2011, due to the discontinuation of support from MERCK.)
Information provided by (Responsible Party):
Pediatric Brain Tumor Consortium Identifier:
First received: December 11, 2007
Last updated: March 2, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2011
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)